TCM
ATRA icon

Tang Capital Management’s Atara Biotherapeutics ATRA Stock Holding History

Tang Capital Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-75,196
Closed -$447K – 203
2025
Q1 		$447K Hold
75,196
– – 0.02% 186
2024
Q4 		$1M Hold
75,196
– – 0.07% 144
2024
Q3 		$611K Hold
75,196
– – 0.04% 132
2024
Q2 		$639K Sell
75,196
-1
-0% -$15 0.07% 103
2024
Q1 		$1.3M Buy
+75,197
New +$1.34M 0.14% 83

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return